T

Takeda Pharmaceutical Company Limited

TAK

13.840
USD
-0.05
(-0.36%)
مغلق
حجم التداول
36,304
الربح لكل سهم
0
العائد الربحي
0
P/E
45
حجم السوق
44,758,391,854
أصول ذات صلة
ABBV
4.380
(2.36%)
189.700 USD
AMGN
2.78
(0.84%)
335.22 USD
AZN
2.040
(2.58%)
81.200 USD
BMY
0.620
(1.30%)
48.180 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
NVS
0.650
(0.58%)
112.100 USD
PFE
0.115
(0.38%)
30.650 USD
SNY
-0.090
(-0.17%)
51.700 USD
الأخبار المقالات

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.